University Of Texas Investment Managment as of June 30, 2017
Portfolio Holdings for University Of Texas Investment Managment
University Of Texas Investment Managment holds 24 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Williams Partners | 20.6 | $6.9M | 173k | 40.11 | |
| Vanguard Europe Pacific ETF (VEA) | 10.1 | $3.4M | 83k | 41.32 | |
| Vanguard S&p 500 Etf idx (VOO) | 9.0 | $3.0M | 14k | 222.05 | |
| Vanguard Mid-Cap Value ETF (VOE) | 8.9 | $3.0M | 29k | 102.87 | |
| Vanguard Emerging Markets ETF (VWO) | 7.8 | $2.6M | 64k | 40.84 | |
| Texas Instruments Incorporated (TXN) | 7.3 | $2.5M | 32k | 76.94 | |
| Aeglea Biotherapeutics | 6.0 | $2.0M | 525k | 3.85 | |
| Bio-path Holdings | 4.3 | $1.5M | 3.8M | 0.38 | |
| Miragen Therapeutics | 4.0 | $1.4M | 106k | 12.93 | |
| Apollo Endosurgery | 3.6 | $1.2M | 154k | 7.89 | |
| Exxon Mobil Corporation (XOM) | 3.4 | $1.1M | 14k | 80.71 | |
| General Moly Inc Com Stk | 3.2 | $1.1M | 2.9M | 0.37 | |
| Vanguard Energy ETF (VDE) | 2.7 | $908k | 10k | 88.50 | |
| Vanguard REIT ETF (VNQ) | 2.3 | $765k | 9.2k | 83.25 | |
| Lexicon Pharmaceuticals (LXRX) | 1.8 | $587k | 36k | 16.44 | |
| Global Blood Therapeutics In | 1.4 | $487k | 18k | 27.36 | |
| Jounce Therapeutics | 1.3 | $428k | 31k | 14.04 | |
| Plx Pharma | 1.1 | $385k | 63k | 6.14 | |
| Park Hotels & Resorts Inc-wi (PK) | 0.8 | $258k | 9.6k | 26.91 | |
| Monsanto Company | 0.2 | $61k | 515.00 | 118.45 | |
| Johnson & Johnson (JNJ) | 0.0 | $6.0k | 47.00 | 127.66 | |
| Discovery Communications | 0.0 | $7.0k | 290.00 | 24.14 | |
| Portland General Electric Company (POR) | 0.0 | $5.0k | 118.00 | 42.37 | |
| Discovery Communications | 0.0 | $3.0k | 115.00 | 26.09 |
